Development of an Efficacious, Semisynthetic Glycoconjugate Vaccine Candidate against Streptococcus pneumoniae Serotype 1

Bibliographic Details
Main Authors: Benjamin Schumann, Katrin Reppe, Paulina Kaplonek, Annette Wahlbrink, Chakkumkal Anish, Martin Witzenrath, Claney L. Pereira, Peter H. Seeberger
Format: Article
Language:English
Published: American Chemical Society 2018-03-01
Series:ACS Central Science
Online Access:http://dx.doi.org/10.1021/acscentsci.7b00504
_version_ 1818356445241933824
author Benjamin Schumann
Katrin Reppe
Paulina Kaplonek
Annette Wahlbrink
Chakkumkal Anish
Martin Witzenrath
Claney L. Pereira
Peter H. Seeberger
author_facet Benjamin Schumann
Katrin Reppe
Paulina Kaplonek
Annette Wahlbrink
Chakkumkal Anish
Martin Witzenrath
Claney L. Pereira
Peter H. Seeberger
author_sort Benjamin Schumann
collection DOAJ
first_indexed 2024-12-13T19:57:19Z
format Article
id doaj.art-c646231788eb41d0a0fc2a0f3df0478c
institution Directory Open Access Journal
issn 2374-7943
2374-7951
language English
last_indexed 2024-12-13T19:57:19Z
publishDate 2018-03-01
publisher American Chemical Society
record_format Article
series ACS Central Science
spelling doaj.art-c646231788eb41d0a0fc2a0f3df0478c2022-12-21T23:33:17ZengAmerican Chemical SocietyACS Central Science2374-79432374-79512018-03-014335736110.1021/acscentsci.7b00504Development of an Efficacious, Semisynthetic Glycoconjugate Vaccine Candidate against Streptococcus pneumoniae Serotype 1Benjamin Schumann0Katrin Reppe1Paulina Kaplonek2Annette Wahlbrink3Chakkumkal Anish4Martin Witzenrath5Claney L. Pereira6Peter H. Seeberger7Max Planck Institute of Colloids and Interfaces, Potsdam, GermanyDivision of Pulmonary Inflammation, Department of Infectious Diseases and Pulmonary Medicine, Charité-Universitätsmedizin Berlin, Berlin, GermanyMax Planck Institute of Colloids and Interfaces, Potsdam, GermanyMax Planck Institute of Colloids and Interfaces, Potsdam, GermanyMax Planck Institute of Colloids and Interfaces, Potsdam, GermanyDivision of Pulmonary Inflammation, Department of Infectious Diseases and Pulmonary Medicine, Charité-Universitätsmedizin Berlin, Berlin, GermanyMax Planck Institute of Colloids and Interfaces, Potsdam, GermanyMax Planck Institute of Colloids and Interfaces, Potsdam, Germanyhttp://dx.doi.org/10.1021/acscentsci.7b00504
spellingShingle Benjamin Schumann
Katrin Reppe
Paulina Kaplonek
Annette Wahlbrink
Chakkumkal Anish
Martin Witzenrath
Claney L. Pereira
Peter H. Seeberger
Development of an Efficacious, Semisynthetic Glycoconjugate Vaccine Candidate against Streptococcus pneumoniae Serotype 1
ACS Central Science
title Development of an Efficacious, Semisynthetic Glycoconjugate Vaccine Candidate against Streptococcus pneumoniae Serotype 1
title_full Development of an Efficacious, Semisynthetic Glycoconjugate Vaccine Candidate against Streptococcus pneumoniae Serotype 1
title_fullStr Development of an Efficacious, Semisynthetic Glycoconjugate Vaccine Candidate against Streptococcus pneumoniae Serotype 1
title_full_unstemmed Development of an Efficacious, Semisynthetic Glycoconjugate Vaccine Candidate against Streptococcus pneumoniae Serotype 1
title_short Development of an Efficacious, Semisynthetic Glycoconjugate Vaccine Candidate against Streptococcus pneumoniae Serotype 1
title_sort development of an efficacious semisynthetic glycoconjugate vaccine candidate against streptococcus pneumoniae serotype 1
url http://dx.doi.org/10.1021/acscentsci.7b00504
work_keys_str_mv AT benjaminschumann developmentofanefficacioussemisyntheticglycoconjugatevaccinecandidateagainststreptococcuspneumoniaeserotype1
AT katrinreppe developmentofanefficacioussemisyntheticglycoconjugatevaccinecandidateagainststreptococcuspneumoniaeserotype1
AT paulinakaplonek developmentofanefficacioussemisyntheticglycoconjugatevaccinecandidateagainststreptococcuspneumoniaeserotype1
AT annettewahlbrink developmentofanefficacioussemisyntheticglycoconjugatevaccinecandidateagainststreptococcuspneumoniaeserotype1
AT chakkumkalanish developmentofanefficacioussemisyntheticglycoconjugatevaccinecandidateagainststreptococcuspneumoniaeserotype1
AT martinwitzenrath developmentofanefficacioussemisyntheticglycoconjugatevaccinecandidateagainststreptococcuspneumoniaeserotype1
AT claneylpereira developmentofanefficacioussemisyntheticglycoconjugatevaccinecandidateagainststreptococcuspneumoniaeserotype1
AT peterhseeberger developmentofanefficacioussemisyntheticglycoconjugatevaccinecandidateagainststreptococcuspneumoniaeserotype1